Scan for other income-focused opportunities with similar traits by reviewing our hand picked list of 33 high quality undervalued stocks alongside Plains GP Holdings' high earnings yield profile.
To own Plains GP Holdings, you need to be comfortable with a crude oil focused midstream model that leans on fee based pipeline, gathering and storage volumes in North America. The big near term swing factor is how efficiently the company executes its growth capital program and cost savings plan, because these directly influence cash generation and earnings quality.
The key operational risk right now is concentration in crude infrastructure after the NGL exit. If producer activity or competing routes leave core systems underused, returns on that asset base could suffer. The latest value focused attention and earnings yield story do not materially change that volume and utilization risk.
The most relevant recent development for this news context is the sharpened focus on crude midstream operations after selling the Canadian NGL business for about US$3.3b in net cash and directing capital into projects like Permian gathering and the Cactus III expansion. That simplified footprint is exactly what current value screens are picking up.
Those moves tie directly into the near term catalysts investors are watching. A 2026 growth capital plan of US$400 million to US$450 million, a leverage target around 3.3x, and a multiyear efficiency program aiming for US$100 million of annual cost savings by 2027 all relate to whether Plains GP Holdings can convert its high earnings yield profile into steadier EBITDA, better coverage of its 6.08% dividend, and a more resilient crude focused platform.
Plains GP Holdings' current analyst narrative points to revenues of US$62.3b and earnings of US$622.8m by 2029, based on an assumed 6.0% yearly revenue growth rate and a move from a reported loss of about US$1.2b today to positive earnings in that forecast year, which represents roughly a 1.6b earnings swing over the period.
Uncover why Plains GP Holdings' fair value indicates a 4% potential downside to its current price, leaving little room for error.
One alternate view around Plains GP Holdings focuses on cost savings risk rather than crude volume upside. The most cautious analysts were only penciling in about US$58.0b of revenue and US$499.9m of earnings by 2029 before this news. That is a much more pessimistic path. Use that spread to stress test your own assumptions because these pre news narratives may shift.
Explore 4 other Plains GP Holdings fair value estimates, including one that suggests as much as 24% downside from the current price.
Don't just follow the ticker; dig into the data and build a conviction that's truly your own.
If you like the income and valuation angle around Plains GP Holdings but want a broader watchlist, the Simply Wall St Screener can help you surface other stocks with different risk and return profiles that still respect balance sheet strength and cash generation.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com